Photo detail

Stories this photo appears in:

SD 500: Kevin Gorman

Health & Science

Kevin Gorman is the CEO of Neurocrine Biosciences, where he’s led the drugmaker’s product from the labs to the market. The company makes a drug called Ingrezza, which just earned FDA approval in 2017.

Tease photo